Mark Levine, MD
Ontario Clinical Oncology Group (OCOG)
13
6
12
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+6 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (13)
Showing 10 of 13 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
John J You, MD MSc FRCPC
McMaster University
Shared therapeutic areas:
Worked with same sponsors:
Sebastien Hotte, MD
Juravinski Cancer Centre
Shared therapeutic areas:
Worked with same sponsors:
Greg Pond, PhD
Ontario Clinical Oncology Group (OCOG)
Shared therapeutic areas:
Worked with same sponsors:
Ur Metser, MD
Princess Margaret Hospital, Canada
Shared therapeutic areas:
Worked with same sponsors:
Jim Julian, MMath
McMaster University, Dept of Clinical Epidemiology & Biostatistics
Shared therapeutic areas:
Worked with same sponsors:
James Perry, MD
Toronto Sunnybrook Regional Cancer Centre
Shared therapeutic areas:
Worked with same sponsors:
Scott Laurie, MD
Ottawa General Hospital Cancer Centre
Shared therapeutic areas:
Worked with same sponsors:
Steven Gallinger, MD
University Health Network: Mount Sinai Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jeffrey Weitz, MD
Hamilton Health Sciences and McMaster University
Shared therapeutic areas:
Worked with same sponsors:
Ian Dayes, MD
Juravinski Hospital and Cancer Centre
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (13)
Showing 13 of 13 trials
Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer
Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging
Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients
Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1
Randomized Trial of Follow-up Strategies in Breast Cancer
The Roles of Tissue Factor in Malignant Gliomas
Shorter Radiation Schedule for the Treatment of Prostate Cancer
Impact of Positron Emission Tomography Imaging Prior to Liver Resection for Colorectal Adenocarcinoma Metastases
RAPID: Randomized Trial of Accelerated Partial Breast Irradiation
Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study
A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy
All 13 trials loaded